PyInvesting

Market research

ABNX.PA ABIONYX Pharma SA

PA EUR Healthcare

Latest close

1.57 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
72M
P/E ratio
Not available
Analyst target
9.75
Dividend yield
Not available
Beta
0.91

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

ABIONYX Pharma SA is currently in a long term uptrend where the price is trading 1.4% above its 200 day moving average.

From a valuation standpoint, the stock is 59.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 109.7.

Based on the above factors, ABIONYX Pharma SA gets an overall score of 2/5.